Jun 12, 2026 07:01AM
Jun 12, 2026 07:00AM
May 7, 2026 04:00PM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Mar 27, 2026 03:02PM
Mar 27, 2026 12:00PM Chardan Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT) amid FDA accelerated approval
Mar 27, 2026 07:01AM
Mar 27, 2026 07:00AM
Feb 26, 2026 04:00PM
Jan 5, 2026 07:00AM
Dec 9, 2025 11:57AM
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 10, 2025 04:00PM
Oct 3, 2025 07:06AM
Aug 28, 2025 07:00AM
Aug 21, 2025 06:22AM
Aug 20, 2025 02:11PM Goldman Sachs Reiterates Sell Rating on Rocket Pharmaceuticals (RCKT), PT $2,
Aug 20, 2025 01:58PM
Aug 20, 2025 07:00AM
Aug 20, 2025 07:00AM
Aug 8, 2025 05:35AM
Aug 7, 2025 04:00PM
Aug 7, 2025 09:25AM
Jul 29, 2025 03:05PM Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
Jul 25, 2025 06:14AM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 22, 2025 05:25PM
Jul 22, 2025 03:51PM
Jul 22, 2025 12:38PM
Jul 20, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 19, 2025 08:05AM
Jul 18, 2025 01:07PM
Jul 18, 2025 12:27PM
Jul 18, 2025 06:15AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 16, 2025 04:16PM CLASS ACTION NOTICE: Berger Montague Advises Rocket Pharmaceuticals (RCKT) Investors to Inquire About a Securities Fraud Class Action
Jul 15, 2025 08:30AM
Jul 14, 2025 05:11PM
Jul 14, 2025 04:00PM
Jul 14, 2025 12:30PM
Jul 13, 2025 07:59AM
Jul 10, 2025 04:51PM
Jul 9, 2025 02:25PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
Jul 8, 2025 07:08PM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All